Victory Capital Management Inc Paratek Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.97 - $5.22 $18,981 - $33,361	-6,391 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.67 - $4.97 $3,681 - $6,853	1,379 Added 27.51%	6,391 $20,000
Q4 2019 Feb 04, 2020	BUY	$2.93 - $4.5 $149 - $229	51 Added 1.03%	5,012 $17,000
Q3 2019 Nov 12, 2019	BUY	$3.08 - $5.76 $15,279 - $28,575	4,961 New	4,961 $21,000
Q4 2017 Feb 01, 2018	SELL	$17.45 - $25.6 $551,594 - $809,216	-31,610 Closed	0 $0
Q3 2017 Oct 27, 2017	SELL	$18.9 - $28.2 $12,851 - $19,176	-680 Reduced 2.11%	31,610 $793,000
Q2 2017 Aug 07, 2017	BUY	N/A	32,290	32,290 $778,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.